SynthesisFrontiers in medicine2026
Leptin, adiponectin levels and their ratios in women with polyendocrine metabolic ovarian syndrome: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome [PCOS]) is a common endocrine and metabolic disorder. The global burden of PMOS shows an overall increasing trend. Recent studies have revealed significant alterations in serum leptin and adiponectin levels in patients with PMOS. However, the results are inconsistent. Objective: To compare the serum leptin and adiponectin levels, as well as the adiponectin-to-leptin (A/L) ratio, between women with PMOS (diagnosed according to the Rotterdam criteria) and healthy controls aged 18-49 years and to provide evidence for future screening strategies and the investigation of the pathogenesis of PMOS. Methods: A comprehensive search of "PubMed," "Web of Science," "Embase," and "Cochrane Library" was conducted from January 1, 2015, to March 31, 2026. The authors independently reviewed all relevant clinical trials via systematic evaluation of abstracts and titles. Results: A total of 62 studies met the inclusion criteria. The pooling analysis of all relevant studies revealed that adult women with PMOS had higher serum leptin levels (standardized mean difference (SMD): 0.83; 95% confidence interval (CI): 0.59 to 1.07; Conclusion: Women with PMOS aged 18-49 exhibit higher leptin levels, lower adiponectin levels and a lower A/L ratio. Further well-designed adequately powered prospective studies are needed to clarify the association between these markers and PMOS, including assessments of their sensitivity, specificity, and optimal cutoff values for predicting PMOS risk. Systematic review registration: The protocol was registered on https://www.crd.york.ac.uk/PROSPERO/view/CRD420261364408 (CRD420261364408).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.